INTRODUCTION

Psoriasis, a complex inflammatory skin disease
Psoriasis is a multifactorial skin disorder affecting about 2-3% of the population worldwide, although it is more prevalent in European, American and Canadian populations. The most common form of chronic plaque psoriasis is Psoriasis vulgaris, which is characterized by epidermal hyperplasia, intensified and abnormal dermal angiogenesis and infiltration of inflammatory cells. Several studies focused mainly on the lesional skin and as a result of these efforts now it is well characterized that psoriasis is a chronic, inflammatory skin disease in which both innate and adaptive immune activation play a role in the manifestation and the maintenance of the abnormal skin phenotype. However, much less is known about the contribution of resident cells of the tissue to the pathology of the disease. Therefore, we focused on to seek for alterations in tissue responses in psoriasis by investigating the phenotypically normal looking non-lesional (NL) psoriatic skin.
The role of fibronectin-binding integrins
Integrins are cell-surface heterodimeric transmembrane receptors consisting of an α and a β subunit known to play essential roles in connecting the intracellular cytoskeleton with various components of the extracellular matrix (ECM). Fibronectin (FN) is a protein secreted as a soluble dimer and through interactions with integrins they form fibrillar structures. The main FN receptor α 5 β 1 integrin was found to be overexpressed in the NL psoriatic epidermis relative to normal. A possible explanation of α 5 integrin overexpression in NL skin is the presence of FN and one of its isoforms, the extra-domain-A containing fibronectin (EDA + FN) in the microenvironment of basal keratinocytes. These two domains could be inserted/excluded through alternative splicing. The cellular form of FN contains the EDA domain and found incorporated into the ECM of tissues. The production of alternatively spliced forms is the highest during embryonic development.
Postnatal the amount of the protein is reduced and further decreases with ageing. However, elevated amount of the EDA + FN is observed during tissue repair, wound healing, angiogenesis and in highly proliferating adult tissues, it can influence cell adhesion, differentiation, cell cycle progression.
Structure and function of KGF and FGFR2
Fibroblast growth factors (FGFs) are small growth factor polypeptides. The family of FGF consists of 23 members with a common structural characteristic. Fibroblast growth factor 7 (FGF7), also known as keratinocyte growth factor (KGF) is produced by cells of mesenchymal origin and considered to be a major growth factor for keratinocytes. In the skin KGF is produced by dermal fibroblasts and keratinocytes can influence its production through interleukin 1 (IL-1). KGF is known to induce keratinocyte proliferation and differentiation.
There is also evidence suggesting that fibroblasts from L and NL skin of psoriatic patients induce keratinocyte outgrowth by producing soluble signals. Indirect evidence, such as measurement of mitogenic activity, suggests that the specific receptor for KGF on epithelial cells is the IIIb splice variant of fibroblast growth factor receptor 2 (FGFR2). Finally, the activation of the signal transducer and activator of transcription (STAT) pathway depends on cellular context.
Roles of KGF and FGFR2 in pathophysiology and therapy
There are several pieces of evidence highlighting the important function of KGF in the processes of wound healing, tissue regeneration and repair. The paracrine signaling functions of KGF are explored for their therapeutic potential in mucositis and wound healing. Genetic alterations of FGFR2 that cause dysregulation of FGFR2 signaling can lead to the development of congenital disorders and acquired diseases including melanoma, Apert syndrome and atopic dermatitis among others. The FGFR2 gene is mutated in Apert syndrome, where ligand specificity experiments showed that the mesenchymally expressed FGF7 is able to bind thereby to activate the mesenchymal splice form of FGFR2 (FGFR2-IIIc).
The role of the JAK-STAT signaling in human diseases
The Janus kinase (JAK)-STAT pathway plays an important role in both innate and adaptive immunity and contributes to the manifestation of several inflammatory processes. In mammals the JAK family consists of four tyrosine kinases, while the STAT family has seven members. JAK-STAT is activated by over 50 cytokines and growth factors, these cytokines include interferons, colony stimulating factors, several interleukins and hormones. Dimerized
JAKs autophosphorilate and become activated enabling STAT binding and phosphorylation.
Phosphorylated STAT monomers form dimers that are translocated into the nucleus of the cell and influence transcription of several genes. Several studies revealed alterations in the JAK-STAT signaling in chronic skin diseases including psoriasis, atopic dermatitis and melanoma.
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STAT1 was observed to be localized predominantly in the horny layer in normal skin by immunostaining. Impaired phosphorylation of STAT1 and STAT5 was described to cause defective response to IL-2 in melanoma from stage III to IV. STAT1 in tumors functions as a suppressor probably by mediating the TNFα triggered apoptotic program. Patients with STAT1
loss-of-function mutations are more prone to mycobacterial and viral infections, whereas gainof-function mutations increase susceptibility to fungal infections.
AIMS
The pathogenesis of psoriasis is still not fully understood, numerous studies have proposed hypotheses regarding to immune dysregulations, skin microbiota system or extracellular matrix alterations among others to play essential roles in the development of the disease. A continuously growing body of evidence indicate that the healthy looking NL psoriatic skin represents an unbalanced phenotype and carries structural alterations compared to normal skin making it susceptible for developing the disease. Abnormalities of the basement membrane at the dermal-epidermal junction (DEJ) render the uninvolved skin to become activated and present a chronic wound healing phenotype.
FN is capable to enhance cell cycle entry, without the increase of adhesion, in uninvolved, but not normal keratinocytes, even in the absence of T cell lymphokines. 
MATERIALS AND METHODS
Skin biopsies
Samples were collected from 16 patients and 25 healthy volunteers for the experiments. Mechanical stress was induced by tape-stripping procedure, and then punch biopsies were taken from NL skin of psoriatic patients (n=6) and from healthy (n=6) subjects from tape-stripped and non-treated skin area from the buttock area at 24 and 48 hours after treatment for all other experiments tissues without the introduction of mechanical stress were used.
Cell culture
Primary keratinocytes, melanocytes and fibroblasts were obtained from healthy participants or psoriatic patients by enzymatic digestion of skin biopsies according to a standard protocol. Fibroblasts, keratinocytes, melanocytes, and HaCaT cells were cultured at 37°C and 5% CO 2 in humidified standard conditions.
Fibroblasts, keratinocytes and HaCaT cells were cultured in 6-well plates at a starting density of 200,000 cells/well and incubated with 25 ng/mL KGF for 24 h; untreated cells were used as controls. For KGF signaling pathway blocking experiments the following inhibitors were used: MEK1 inhibitor, AKT ½ kinase inhibitor, STAT1 inhibitor and STAT3 inhibitor, concentrations were applied as previously described.
RNA extraction and real-time quantitative reverse transcription polymerase chain reaction (RT qRT-PCR)
Cells on 6 well plates were washed once with PBS, then harvested with 0.5 ml TRIzol 
Immunofluorescent staining
Human punch biopsies were frozen embedded, stored at -80 °C, then cut into 6 µm 
Expression of FGFR2 splice variants in fibroblasts, melanocytes and keratinocytes
Two splice variants have been identified for FGFR2 designated as FGFR2-IIIb and Therefore, we investigated the phosphorylation pattern of STAT1 at Tyr701 and Ser727
positions that are known to be key amino acid modifications leading to dimerization and influencing activity. Immunofluorescent staining for the phosphorylated Ser727 was highest in lesional psoriatic skin, lower, but clearly detectable in healthy skin, whereas NL skin samples showed the lowest intensity. In two out of four investigated NL samples phosphorylation was undetectable. Staining for the phosphorylated Tyr701 showed a much less noticeable but similar pattern. In samples of patients where no serine phosphorylation was detected in the NL skin, the staining for the phosphorylated Tyr701 was also not visible in either NL or lesional areas.
To elucidate whether differences observed in STAT1 activity among patients correlated with the severity of the disease, PASI scores of donor patients were compared. The patients whose NL skin was negative for phosphorylations of STAT1 had a lower PASI score (12.4 and 17.8),
whereas low STAT1 activity in NL skin was associated with a higher PASI score (19.6 and 20) .
Immunhistochemistry analysis revealed the presence of pSTAT1 (Ser727) in the both the epidermis and the dermis. STAT1 activity showed a strong correlation with PASI score. High PASI scores (eg. 19.6) were typically coupled with intensive pSTAT1 (Ser727) staining in the lesional skin and in these patients, the NL skin also showed a slight STAT1 activity. In contrast, patients with low PASI score (eg. 9.8) nearly no STAT1 activity was detectable in the NL skin.
Indicating that pSTAT1 (Ser727) activation of the NL skin and the PASI scores of patients decreased in parallel. Activation of STAT1 Tyr (701) form decays rapidly and only in samples obtained from patient with high PASI score can be observed, where the presence of both phosphorylated forms is much more intensive. We compared NL skin samples near and far from the lesion for the extent of activation for the two different pSTAT1 forms in order to test whether the lesional area has an effect on surrounding NL skin. It was assessed that STAT1 activity is independent from the distance from the lesion indicating a sharp border between the NL and lesional skin. The strongest STAT1 activation is detected in psoriatic L skin.
In silico model construction
We constructed an in silico model based on our in vitro results involving KGF-and FNsignaling and the underlying transcriptional regulation network. Our data already suggested the participation of MAPK signaling in KGF induced FN splicing. The generated co-expression matrix implied a potential role of peptidyl-prolyl cis-trans isomerase (PPIG), a protein important in both protein folding and splicing, which is regulated by MEK1 induced AP-1.
Changes in MEK1 activity could lead to the modulation of FN splicing through PPIG resulting in elevated EDA + FN levels. Our model also indicated that STAT3 negatively regulates the expression of MEK1. This suggested inhibitory effect of STAT3 on MEK1 may account for the increased EDA + FN production upon STAT inhibition.
SUMMARY
In psoriasis the NL skin already contains abnormalities that are likely to serve as a Last, but not least I am also very grateful to all members of my family who helped me with their endless love, patience, support and encouragement.
